stavudine/d4T
A Phase I/II Evaluation of Stavudine (d4T) in Children With Human Immunodeficiency Virus Infection
8
Combination Therapy With Stavudine (d4T) Plus Didanosine (ddI) in Children With Human Immunodeficiency Virus Infection
8
Sustained heavy ethanol drinking affects CD4+ cell counts in HIV infected patients on stavudine (d4T), lamivudine (3TC) and nevirapine (NVP) treatment regimen during 9 months follow up period
10
Chronic Alcohol Consumption Affects Serum Enzymes Levels in the HIV Infected Patients on Stavudine (d4T)/Lamivudine (3TC)/Nevirapine (NVP) Treatment Regimen
14
beta estradiol attenuates the anti HIV 1 efficacy of Stavudine (D4T) in primary PBL
8
A Randomized Comparative Trial of Stavudine (d4T) Versus Zidovudine (ZDV, AZT) in Children With Human Immunodeficiency Virus Infection
9
Complete Phase-Out Stavudine Based Regimens in the Treatment of HIV-Infection: is it True That Stavudine Hasn’t Any Benefit Today? A Review
5
FORMULATION, DEVELOPMENT AND EVALUATION OF MUCOADHESIVE MICROSPHERE OF STAVUDINE
8
Prevalence of HIV 1 drug resistance amongst newly diagnosed HIV infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13
7
Formulation and in-vitro evaluation of stavudine extended release tablets
11
A Time to Event Analysis of Adverse Drug Reactions Due to Tenofovir, Zidovudine and Stavudine in a Cohort of Patients Receiving Antiretroviral Treatment at an Outpatient Clinic in Zimbabwe
6
Changes in Serum Liver Enzymes Level after Switching from Stavudine/Lamivudine to Zidovudine/Lamivudine in NNRTIs Based Anti-Retroviral Regimens in Hawassa, Southern Ethiopia
7
Microspheres Embedded In Microbeads: A Novel Approach to Improve Various Controlled Release Characteristics of Highly Water Soluble Drug through Ionic Gelation Method
6
Changes in immunological, biochemical and hematological parameters of HIV-1 positive patients on antiretroviral therapy in Mbagathi County Hospital, Nairobi
119
A Novel Genetic Pathway of Human Immunodeficiency Virus Type 1 Resistance to Stavudine Mediated by the K65R Mutation
9
HIV, antiretroviral therapy, and tuberculosis : outcomes in Johannesburg, South Africa
238
cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011
6
High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China
8
Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
7
UK national clinical audit: management of pregnancies in women with HIV
6